Clinical Study
Hypertension Control and Cardiometabolic Risk: A Regional Perspective
Table 6
Blood pressure and LDL-Cholesterol (mmol/L ± SD, adjusted for age, gender, and diabetes).
| | Total
(,529) | Northern Europe
() | Southern Europe
() | North America
() | Middle East
() | Asia
() | value |
| | SBP (mmHg) | | | | | | | | | <120 | 2.9 (0.044) | 3.0 (0.088) | 3.0 (0.076) | 2.5 (0.109) | 2.8 (0.231) | 2.8 (0.093) | 0.0003 | | 120–139 | 3.0 (0.048) | 3.1 (0.035) | 3.0 (0.028) | 2.4 (0.054) | 2.9 (0.121) | 2.9 (0.042) | <0.0001 | | 140–159 | 3.2 (0.015) | 3.2 (0.025) | 3.2 (0.024) | 2.6 (0.053) | 3.4 (0.075) | 3.0 (0.038) | <0.0001 | | 160–179 | 3.3 (0.020) | 3.3 (0.033) | 3.3 (0.032) | 2.7 (0.081) | 3.5 (0.080) | 3.3 (0.057) | <0.0001 | | ≥180 | 3.4 (0.034) | 3.4 (0.055) | 3.5 (0.058) | 3.0 (0.153) | 3.9 (0.131) | 3.5 (0.096) | <0.0001 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.0005 | <0.0001 | | | DBP (mmHg) | | | | | | | | | <90 | 3.0 (0.013) | 3.1 (0.022) | 3.1 (0.021) | 2.4 (0.037) | 3.0 (0.081) | 2.9 (0.031) | <0.0001 | | 90–99 | 3.3 (0.016) | 3.3 (0.028) | 3.3 (0.027) | 2.8 (0.074) | 3.4 (0.073) | 3.1 (0.045) | <0.0001 | | 100–109 | 3.4 (0.026) | 3.4 (0.047) | 3.4 (0.041) | 2.9 (0.141) | 3.9 (0.098) | 3.4 (0.069) | <0.0001 | | ≥110 | 3.5 (0.049) | 3.5 (0.086) | 3.6 (0.080) | 3.9 (0.311) | 3.5 (0.169) | 3.6 (0.151) | 0.5736 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | | | RR (mmHg) | | | | | | | | | uncontrolled* | 3.4 (0.014) | 3.3 (0.019) | 3.3 (0.018) | 2.7 (0.042) | 3.5 (0.050) | 3.1 (0.029) | <0.0001 | | controlled** | 3.0 (0.012) | 3.0 (0.034) | 3.0 (0.027) | 2.4 (0.050) | 2.9 (0.115) | 2.9 (0.040) | <0.0001 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
|
|
*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.
|
